Detection and Analysis of EGFR and KRAS Mutations in the Patients with Lung Squamous Cell Carcinomas
Background and objective Activating mutations in epidermal growth factor receptor (EGFR) and KRAS are important markers in non-small cell lung cancer. However, EGFR and KRAS gene mutations in lung squamous cell carcinoma are rarely reported. The aim of this study was to analyze EGFR and KRAS gene mu...
Main Authors: | Hui ZHANG, Xinjie YANG, Na QIN, Xi LI, Huiyi YANG, Jingying NONG, Jialin LV, Yuhua WU, Quan ZHANG, Xinyong ZHANG, Jinghui WANG, Dan SU, Shucai ZHANG |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2015-10-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2015.10.04 |
Similar Items
-
Detection and Analysis of EGFR and KRAS Mutation with Lung Adenocarcinoma
by: Hui ZHANG, et al.
Published: (2015-11-01) -
Clinical Analysis of 107 NSCLC Patients Harboring KRAS Mutation
by: Quan ZHANG, et al.
Published: (2016-05-01) -
Clinical Observation of Icotinib Hydrochloride for Advanced Non-small Cell Lung Cancer Patients with EGFR Status Identified
by: Xi LI, et al.
Published: (2015-12-01) -
Evaluation of EGFR, KRAS and BRAF gene mutations in renal cell carcinoma
by: Omer Bayrak, et al.
Published: (2014-08-01) -
Comparison of EGFR and KRAS Status between Primary Non-small Cell Lung Cancer and Corresponding Metastases: A Systematic Review and meta-analysis
by: Chengbo HAN, et al.
Published: (2010-09-01)